Hannah Joseph Ipo
Hannah Joseph Hospital IPO Review & Key Points
Review: Neutral
IPO Lead Managers aka Merchant Bankers
Capital Square Advisors Pvt.Ltd
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 4,000 | ₹2,80,000 |
| Retail Maximum | 2 | 4,000 | ₹2,80,000 |
| S-HNI Minimum | 3 | 6,000 | ₹4,20,000 |
| S-HNI Maximum | 7 | 14,000 | ₹9,80,000 |
| B-HNI Minimum | 8 | 16,000 | ₹11,20,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 17,06,000 Shares | 28.43% |
| QIB (Ex. Anchor) | 11,44,000 Shares | 19.07% |
| NII Shares Offered | 8,55,000 Shares | 14.25% |
| Retail Shares Offered | 19,95,000 Shares | 33.25% |
| Anchor Bidding Date | January 21, 2026 |
| Anchor Investors List | |
| Shares Offered | 17,06,000 Shares |
| Anchor Size | 11.94 Cr. |
| lock-in period end date 50% shares (30 Days) | February 27, 2026 |
| lock-in period end date 50% shares (90 Days) | April 28, 2026 |
| IPO Open Date: | January 22, 2026 |
| IPO Close Date: | January 28, 2026 |
| Basis of Allotment: | January 29, 2026 |
| Refunds: | January 30 2026 |
| Credit to Demat Account: | January 30, 2026 |
| IPO Listing Date: | February 2, 2026 |
| IPO Bidding Cut-off Time: | January 28, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,66,98,363 | 93.57% |
| Promoter Holding Post Issue | 2,26,98,363 | 68.83% |
| Purpose | Crores |
| Funding of capital expenditure for establishing Radiation Oncology Centre | ₹34.98 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹54.90 | ₹53.88 | ₹1.01 | ₹92.14 |
| 2024 | ₹63.63 | ₹58.29 | ₹4.07 | ₹89.97 |
| 2025 | ₹77.90 | ₹67.55 | ₹7.21 | ₹99.29 |
| Sep 2025 | ₹42.75 | ₹35.70 | ₹5.12 | ₹104.58 |
| KPI | Values |
| ROE: | 14.77% |
| ROCE: | 17.03% |
| EBITDA Margin: | 26.47% |
| PAT Margin: | 9.30% |
| Debt to equity ratio: | 0.65 |
| Earning Per Share (EPS): | ₹4.32 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 14.74% |
| Net Asset Value (NAV): | ₹29.30 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Asarfi Hospital Limited | 5.58 | 32.26 | 13.48% | 41.39 | 128.13 Cr. |
| Maitreya Medicare Limited | 2.80 | 74.29 | 7.10% | 39.49 | 44.85 Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | January 22, 2026 |
| IPO Close Date | January 28, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹67 to ₹70 Per Share |
| Issue Size | Approx ₹42 Crores |
| Fresh Issue | Approx ₹42 Crores |
| Offer for Sale: | Approx [.] Equity Shares |
| Issue Type | Book build issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |